Wird geladen...

The Latest Innovations in the Drug Pipeline for Multiple Sclerosis

Several new medications are being investigated in late-phase studies for the treatment of patients with relapsing or progressive multiple sclerosis (MS). These agents represent a variety of mechanisms of action and provide not only lower relapse rates but also improvement in disabilities. The majori...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Am Health Drug Benefits
Hauptverfasser: Radick, Lea, Mehr, Stanton R.
Format: Artigo
Sprache:Inglês
Veröffentlicht: Engage Healthcare Communications, LLC 2015
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4684635/
https://ncbi.nlm.nih.gov/pubmed/26702336
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!